메뉴 건너뛰기




Volumn 36, Issue 1, 2003, Pages 129-157

Postoperative management of differentiated thyroid cancer

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE; IODINE 131; LEVOTHYROXINE; RECOMBINANT THYROTROPIN; THYROGLOBULIN;

EID: 12244291231     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0030-6665(02)00137-8     Document Type: Review
Times cited : (20)

References (123)
  • 1
    • 0037724456 scopus 로고    scopus 로고
    • American Cancer Society. Cancer facts and figures 2002. Available at: http://www.cancer.org/eprise/main/docroot/stt/stt_0. Accessed August 10, 2002.
    • (2002) Cancer Facts and Figures 2002
  • 2
    • 0031028402 scopus 로고    scopus 로고
    • Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991
    • Gilliland FD, Hunt WC, Morris DM, et al. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer 1997;79(3):564-73.
    • (1997) Cancer , vol.79 , Issue.3 , pp. 564-573
    • Gilliland, F.D.1    Hunt, W.C.2    Morris, D.M.3
  • 3
    • 0032535770 scopus 로고    scopus 로고
    • A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S. 1985-1995
    • Hundahl SA, Fleming ID, Fremgen AM, et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S. 1985-1995. Cancer 1998;83(12):2638-2648.
    • (1998) Cancer , vol.83 , Issue.12 , pp. 2638-2648
    • Hundahl, S.A.1    Fleming, I.D.2    Fremgen, A.M.3
  • 4
    • 0026768192 scopus 로고
    • The results of various modalities of treatment of well differentiated thyroid carcinoma: A retrospective review of 1599 patients
    • Samaan NA, Schultz PN, Hickey RC, et al. The results of various modalities of treatment of well differentiated thyroid carcinoma: a retrospective review of 1599 patients. J Clin Endocrinol Metab 1992;75(3):714-20.
    • (1992) J Clin Endocrinol Metab , vol.75 , Issue.3 , pp. 714-720
    • Samaan, N.A.1    Schultz, P.N.2    Hickey, R.C.3
  • 5
    • 0027135424 scopus 로고
    • Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989
    • Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114(6):1050-8.
    • (1993) Surgery , vol.114 , Issue.6 , pp. 1050-1058
    • Hay, I.D.1    Bergstralh, E.J.2    Goellner, J.R.3
  • 6
    • 0019522882 scopus 로고
    • Papillary thyroid carcinoma: A 10 year follow-up report of the impact of therapy in 576 patients
    • Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 1981;70(3):511-7.
    • (1981) Am J Med , vol.70 , Issue.3 , pp. 511-517
    • Mazzaferri, E.L.1    Young, R.L.2
  • 7
    • 0023695539 scopus 로고
    • Papillary and follicular thyroid cancer: Impact of treatment in 1578 patients
    • Simpson WJ. Panzarella T, Carruthers JS, et al. Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys 1988;14(6):1063-75.
    • (1988) Int J Radiat Oncol Biol Phys , vol.14 , Issue.6 , pp. 1063-1075
    • Simpson, W.J.1    Panzarella, T.2    Carruthers, J.S.3
  • 8
    • 0024261904 scopus 로고
    • Local recurrence in papillary thyroid carcinoma: Is extent of surgical resection important?
    • Grant CS, Hay ID, Gough IR, et al. Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery 1988;104(6):954-62.
    • (1988) Surgery , vol.104 , Issue.6 , pp. 954-962
    • Grant, C.S.1    Hay, I.D.2    Gough, I.R.3
  • 9
    • 0021992510 scopus 로고
    • External radiotherapy in thyroid cancers
    • Tubiana M, Haddad E, Schlumberger M, et al. External radiotherapy in thyroid cancers. Cancer 1985;55(Suppl 9):2062-71.
    • (1985) Cancer , vol.55 , Issue.SUPPL. 9 , pp. 2062-2071
    • Tubiana, M.1    Haddad, E.2    Schlumberger, M.3
  • 10
    • 0036498574 scopus 로고    scopus 로고
    • Papillary thyroid carcinoma: Prognostic factors and the role of radioiodine and external radiotherapy
    • Chow SM, Lw SC, Mendenhall WM, et al. Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy. Int J Rad Oncol Biol Phys 2002;52(3):784-95.
    • (2002) Int J Rad Oncol Biol Phys , vol.52 , Issue.3 , pp. 784-795
    • Chow, S.M.1    Lw, S.C.2    Mendenhall, W.M.3
  • 11
    • 0023689451 scopus 로고
    • Distant metastases in differentiated thyroid carcinoma: A multivariate analysis of prognostic variables
    • Ruegemer JJ, Hay ID, Bergstralh EJ, et al. Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab 1988;67(3):501-8.
    • (1988) J Clin Endocrinol Metab , vol.67 , Issue.3 , pp. 501-508
    • Ruegemer, J.J.1    Hay, I.D.2    Bergstralh, E.J.3
  • 12
    • 0021978711 scopus 로고
    • Pulmonary metastasis of differentiated thyroid carcinoma: Treatment results in 101 patients
    • Samaan NA, Schultz PN, Haynie TP, et al. Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients. J Clin Endocrinol Metab 1985;60(2):376-80.
    • (1985) J Clin Endocrinol Metab , vol.60 , Issue.2 , pp. 376-380
    • Samaan, N.A.1    Schultz, P.N.2    Haynie, T.P.3
  • 13
    • 0023521529 scopus 로고
    • Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system
    • Hay ID, Grant CS, Taylor WF, et al. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987;102(6):1088-94.
    • (1987) Surgery , vol.102 , Issue.6 , pp. 1088-1094
    • Hay, I.D.1    Grant, C.S.2    Taylor, W.F.3
  • 14
    • 0022640101 scopus 로고
    • Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma?
    • Tennvall J, Biorklund A, Moller T, et al. Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma? Cancer 1986;57(7):1405-14.
    • (1986) Cancer , vol.57 , Issue.7 , pp. 1405-1414
    • Tennvall, J.1    Biorklund, A.2    Moller, T.3
  • 15
    • 0024232116 scopus 로고
    • An expanded view of risk-group definition in differentiated thyroid cancer
    • Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid cancer. Surgery 1988;104(6):947-53.
    • (1988) Surgery , vol.104 , Issue.6 , pp. 947-953
    • Cady, B.1    Rossi, R.2
  • 16
    • 0023614583 scopus 로고
    • Papillary and follicular thyroid cancer
    • Simpson WJ, McKinney SE, Carruthers JS, et al. Papillary and follicular thyroid cancer. Am J Med 1987;83(3):479-88.
    • (1987) Am J Med , vol.83 , Issue.3 , pp. 479-488
    • Simpson, W.J.1    McKinney, S.E.2    Carruthers, J.S.3
  • 17
    • 0031963901 scopus 로고    scopus 로고
    • The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid cancer
    • Tsang RW, Brierley JD, Simpson WJ, et al. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid cancer. Cancer 1998;82(2):375-88.
    • (1998) Cancer , vol.82 , Issue.2 , pp. 375-388
    • Tsang, R.W.1    Brierley, J.D.2    Simpson, W.J.3
  • 18
    • 0027053161 scopus 로고
    • Papillary thyroid microcarcinoma: A study of 535 cases observed in a 50-year period
    • Hay ID, Grant CS, van Heerden JA, et al. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 1992;1 12(6):1139-47.
    • (1992) Surgery , vol.112 , Issue.6 , pp. 1139-1147
    • Hay, I.D.1    Grant, C.S.2    Van Heerden, J.A.3
  • 19
    • 0015413604 scopus 로고
    • Papillary carcinoma of the thyroid. Recurrence in the thyroid gland after initial surgical management
    • Tollefson HR, Shah JP, Huvos AG. Papillary carcinoma of the thyroid. Recurrence in the thyroid gland after initial surgical management. Am J Surg 1972;124(4):468-72.
    • (1972) Am J Surg , vol.124 , Issue.4 , pp. 468-472
    • Tollefson, H.R.1    Shah, J.P.2    Huvos, A.G.3
  • 20
    • 0027766813 scopus 로고
    • Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: A matched pair analysis
    • Shah JP, Loree TR, Dharker D, et al. Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched pair analysis. Am J Surg 1993;166(4):331-5.
    • (1993) Am J Surg , vol.166 , Issue.4 , pp. 331-335
    • Shah, J.P.1    Loree, T.R.2    Dharker, D.3
  • 21
    • 0027943619 scopus 로고
    • Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
    • Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97(5):418-28.
    • (1994) Am J Med , vol.97 , Issue.5 , pp. 418-428
    • Mazzaferri, E.L.1    Jhiang, S.M.2
  • 22
    • 0025063417 scopus 로고
    • Natural history, treatment, and course of papillary thyroid carcinoma
    • DeGroot LJ, Kaplan EL, McCormick M. Natural history, treatment, and course of papillary thyroid carcinoma. Clin Endocrinol Metab 1990;71(2):414-24.
    • (1990) Clin Endocrinol Metab , vol.71 , Issue.2 , pp. 414-424
    • DeGroot, L.J.1    Kaplan, E.L.2    McCormick, M.3
  • 24
    • 0036691093 scopus 로고    scopus 로고
    • Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): Temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients
    • Hay ID, Thompson GB, Grant CS, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 2002;26(8):879-85.
    • (2002) World J Surg , vol.26 , Issue.8 , pp. 879-885
    • Hay, I.D.1    Thompson, G.B.2    Grant, C.S.3
  • 25
    • 15644367081 scopus 로고    scopus 로고
    • Outcome after treatment of high-risk papillary and non-Hurthle-cell follicular thyroid carcinoma
    • Taylor T, Specker B, Robbins J, et al. Outcome after treatment of high-risk papillary and non-Hurthle-cell follicular thyroid carcinoma. Ann Intern Med 1998;129(8):622-7.
    • (1998) Ann Intern Med , vol.129 , Issue.8 , pp. 622-627
    • Taylor, T.1    Specker, B.2    Robbins, J.3
  • 26
    • 0020082525 scopus 로고
    • Comparison of 30- and 50-mCi doses of iodine-131 for thyroid ablation
    • Degroot LJ, Reilly M. Comparison of 30- and 50-mCi doses of iodine-131 for thyroid ablation. Ann Intern Med 1982;96(1):51-3.
    • (1982) Ann Intern Med , vol.96 , Issue.1 , pp. 51-53
    • Degroot, L.J.1    Reilly, M.2
  • 27
    • 0026071839 scopus 로고
    • Comparison of 1073 MBq and 3700 MBq iodine-131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancer
    • Johansen K, Woodhouse NJ, Odugbesan O. Comparison of 1073 MBq and 3700 MBq iodine-131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancer. J Nucl Med 1991;32(2):252-4.
    • (1991) J Nucl Med , vol.32 , Issue.2 , pp. 252-254
    • Johansen, K.1    Woodhouse, N.J.2    Odugbesan, O.3
  • 28
    • 0017170264 scopus 로고
    • Low dose radioiodide thyroid ablation in postsurgical patients with thyroid cancer
    • McCowen KD, Adler RA, Ghaed N, et al. Low dose radioiodide thyroid ablation in postsurgical patients with thyroid cancer. Am J Med 1976;61(1):52-8.
    • (1976) Am J Med , vol.61 , Issue.1 , pp. 52-58
    • McCowen, K.D.1    Adler, R.A.2    Ghaed, N.3
  • 29
    • 0022357364 scopus 로고
    • Evaluation of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients
    • Ramanna L, Waxman AD, Brachman MB, et al. Evaluation of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients. Clin Nucl Med 1985;10(11):791-5.
    • (1985) Clin Nucl Med , vol.10 , Issue.11 , pp. 791-795
    • Ramanna, L.1    Waxman, A.D.2    Brachman, M.B.3
  • 30
    • 0021750488 scopus 로고
    • An analysis "ablation of thyroid remnants" with 1-131 in 511 patients from 1947-1984: Experience at University of Michigan
    • Beierwaltes WH, Rabbani R, Dmuchowski C, et al. An analysis "ablation of thyroid remnants" with 1-131 in 511 patients from 1947-1984: experience at University of Michigan. J Nucl Med 1984;25(12):1287-93.
    • (1984) J Nucl Med , vol.25 , Issue.12 , pp. 1287-1293
    • Beierwaltes, W.H.1    Rabbani, R.2    Dmuchowski, C.3
  • 31
    • 0030001231 scopus 로고    scopus 로고
    • 131I for remnant ablation in patients with differentiated thyroid carcinoma
    • 131I for remnant ablation in patients with differentiated thyroid carcinoma. Cancer 1996;77(12):2574-80.
    • (1996) Cancer , vol.77 , Issue.12 , pp. 2574-2580
    • Bal, C.1    Padhy, A.K.2    Jana, S.3
  • 32
    • 0028556247 scopus 로고
    • Radioiodine ablation of residual tissue in thyroid cancer: Relationship between administered activity, neck uptake and outcome
    • Logue JP, Tsang RW, Brierley JD, et al. Radioiodine ablation of residual tissue in thyroid cancer: relationship between administered activity, neck uptake and outcome. Br J Radiol 1994;67(803):1127-31.
    • (1994) Br J Radiol , vol.67 , Issue.803 , pp. 1127-1131
    • Logue, J.P.1    Tsang, R.W.2    Brierley, J.D.3
  • 33
    • 0020518295 scopus 로고
    • Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer
    • Maxon HR, Thomas SR, Hertzberg VS, et al. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med 1983;309(16):937-41.
    • (1983) N Engl J Med , vol.309 , Issue.16 , pp. 937-941
    • Maxon, H.R.1    Thomas, S.R.2    Hertzberg, V.S.3
  • 34
    • 0020595286 scopus 로고
    • Thyroid remnant ablation: Questionable pursuit of an ill-defined goal
    • Snyder J, Gorman C, Scanlon P. Thyroid remnant ablation: questionable pursuit of an ill-defined goal. J Nucl Med 1983;24(8):659-65.
    • (1983) J Nucl Med , vol.24 , Issue.8 , pp. 659-665
    • Snyder, J.1    Gorman, C.2    Scanlon, P.3
  • 35
    • 0036176896 scopus 로고    scopus 로고
    • Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone
    • Berg G, Lindstedt G, Suurküla M, et al. Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone. J Endocrinol Invest 2002;25(1):44-52.
    • (2002) J Endocrinol Invest , vol.25 , Issue.1 , pp. 44-52
    • Berg, G.1    Lindstedt, G.2    Suurküla, M.3
  • 36
    • 0034858135 scopus 로고    scopus 로고
    • Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin
    • Robbins RJ, Tuttle RM, Sonenberg M, et al. Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin. Thyroid 2001;11(9):865-9.
    • (2001) Thyroid , vol.11 , Issue.9 , pp. 865-869
    • Robbins, R.J.1    Tuttle, R.M.2    Sonenberg, M.3
  • 37
    • 0036841049 scopus 로고    scopus 로고
    • A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation
    • Robbins RJ, Larson SM, Sinha N, et al. A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation. J Nucl Med 2002;43(11):1482-8.
    • (2002) J Nucl Med , vol.43 , Issue.11 , pp. 1482-1488
    • Robbins, R.J.1    Larson, S.M.2    Sinha, N.3
  • 38
    • 0030030103 scopus 로고    scopus 로고
    • Differentiated thyroid cancer impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4)
    • Farahati J, Reiners C, Stuschke M, et al. Differentiated thyroid cancer impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Cancer 1996;77(1):172-80.
    • (1996) Cancer , vol.77 , Issue.1 , pp. 172-180
    • Farahati, J.1    Reiners, C.2    Stuschke, M.3
  • 39
    • 0025214324 scopus 로고
    • Survival rates in patients with differentiated thyroid carcinoma. Influence of postoperative external radiotherpy
    • Benker G, Olbricht T, Reinwein D, et al. Survival rates in patients with differentiated thyroid carcinoma. Influence of postoperative external radiotherpy. Cancer 1990;65(7):1517-20.
    • (1990) Cancer , vol.65 , Issue.7 , pp. 1517-1520
    • Benker, G.1    Olbricht, T.2    Reinwein, D.3
  • 40
    • 0027494285 scopus 로고
    • Postoperative irradiation for thyroid cancer
    • Phlips P, Hanzen C, Andry G, et al. Postoperative irradiation for thyroid cancer. Eur J Surg Oncol 1993;19(5):399-404.
    • (1993) Eur J Surg Oncol , vol.19 , Issue.5 , pp. 399-404
    • Phlips, P.1    Hanzen, C.2    Andry, G.3
  • 41
    • 0028333051 scopus 로고
    • Prophylactic external irradiation in differentiated thyroid cancer: A retrospective study over a 30-year observation period
    • Esik O, Nemeth G, Eller J. Prophylactic external irradiation in differentiated thyroid cancer: a retrospective study over a 30-year observation period. Oncology 1994;51(4):372-9.
    • (1994) Oncology , vol.51 , Issue.4 , pp. 372-379
    • Esik, O.1    Nemeth, G.2    Eller, J.3
  • 42
    • 0028276609 scopus 로고
    • Results of external beam radiotherapy in differentiated thyroid carcinoma: A retrospective study from the Royal Marsden Hospital
    • O'Connell ME, A'Hern RP, Harmer CL. Results of external beam radiotherapy in differentiated thyroid carcinoma: a retrospective study from the Royal Marsden Hospital. Eur J Cancer 1994;30A(6):733-9.
    • (1994) Eur J Cancer , vol.30 A , Issue.6 , pp. 733-739
    • O'Connell, M.E.1    A'Hern, R.P.2    Harmer, C.L.3
  • 43
    • 0025500636 scopus 로고
    • Survival discriminants for differentiated thyroid cancer
    • Cunningham MP, Duda RB, Recant W, et al. Survival discriminants for differentiated thyroid cancer. Am J Surg 1990;160(4):344-7.
    • (1990) Am J Surg , vol.160 , Issue.4 , pp. 344-347
    • Cunningham, M.P.1    Duda, R.B.2    Recant, W.3
  • 44
    • 0023901078 scopus 로고
    • Surgically incurable well-differentiated thyroid carcinoma. Prognostic factors and results of therapy
    • Rossi RL, Cady B, Silverman ML, et al. Surgically incurable well-differentiated thyroid carcinoma. Prognostic factors and results of therapy. Arch Surg 1988;123(5):569-73.
    • (1988) Arch Surg , vol.123 , Issue.5 , pp. 569-573
    • Rossi, R.L.1    Cady, B.2    Silverman, M.L.3
  • 45
    • 0029827464 scopus 로고    scopus 로고
    • Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer
    • Pujol P, Daures JP, Nsakala N, et al. Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. J Clin Endocrinol Metab 1996;81(12):4318-4323.
    • (1996) J Clin Endocrinol Metab , vol.81 , Issue.12 , pp. 4318-4323
    • Pujol, P.1    Daures, J.P.2    Nsakala, N.3
  • 46
    • 0017150624 scopus 로고
    • Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma
    • Cady B, Sedgwick CE, Meissner WA, et al. Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma. Ann Surg 1976;184(5):541-53.
    • (1976) Ann Surg , vol.184 , Issue.5 , pp. 541-553
    • Cady, B.1    Sedgwick, C.E.2    Meissner, W.A.3
  • 47
    • 0021073182 scopus 로고
    • The effect of thyroid hormone administration upon survival in patients with differentiated thyroid carcinoma
    • Cady B, Cohn K, Rossi RL, et al. The effect of thyroid hormone administration upon survival in patients with differentiated thyroid carcinoma. Surgery 1983;94(6):978-83.
    • (1983) Surgery , vol.94 , Issue.6 , pp. 978-983
    • Cady, B.1    Cohn, K.2    Rossi, R.L.3
  • 48
    • 13144261746 scopus 로고    scopus 로고
    • Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: Results from the National Thyroid Cancer Treatment Cooperative Registry
    • Cooper DS, Specker B, Ho M, et al. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid 1998;8(9):737-44.
    • (1998) Thyroid , vol.8 , Issue.9 , pp. 737-744
    • Cooper, D.S.1    Specker, B.2    Ho, M.3
  • 49
    • 0019777718 scopus 로고
    • The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancer
    • Ashcraft MW, Van Herle AJ. The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancer. Am J Med 1981;71(5):806-14.
    • (1981) Am J Med , vol.71 , Issue.5 , pp. 806-814
    • Ashcraft, M.W.1    Van Herle, A.J.2
  • 50
    • 0027233732 scopus 로고
    • The role of iodine-131 and thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid carcinoma
    • Dadparvar S, Krishna L, Brady LW, et al. The role of iodine-131 and thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid carcinoma. Cancer 1993;71(11):3767-73.
    • (1993) Cancer , vol.71 , Issue.11 , pp. 3767-3773
    • Dadparvar, S.1    Krishna, L.2    Brady, L.W.3
  • 51
    • 0031966884 scopus 로고    scopus 로고
    • Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma
    • Gallowitsch HJ, Mikosch P, Kresnik E, et al. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma. J Nucl Med 1998;39(5):870-5.
    • (1998) J Nucl Med , vol.39 , Issue.5 , pp. 870-875
    • Gallowitsch, H.J.1    Mikosch, P.2    Kresnik, E.3
  • 52
    • 0028049352 scopus 로고
    • Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma
    • Lubin E, Mechlis-Frish S, Zatz S, et al. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma. J Nucl Med 1994;35(2):257-62.
    • (1994) J Nucl Med , vol.35 , Issue.2 , pp. 257-262
    • Lubin, E.1    Mechlis-Frish, S.2    Zatz, S.3
  • 53
    • 0025005762 scopus 로고
    • Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma?
    • Ronga G, Fiorentino A, Paserio E, et al. Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma?. J Nucl Med 1990;31(11):1766-71.
    • (1990) J Nucl Med , vol.31 , Issue.11 , pp. 1766-1771
    • Ronga, G.1    Fiorentino, A.2    Paserio, E.3
  • 54
    • 0031742512 scopus 로고    scopus 로고
    • Thallium-201, technetium-99m-tetrofosmin and iodine131 in detecting differentiated thyroid carcinoma metastases
    • Unal S, Menda Y, Adalet I, et al. Thallium-201, technetium-99m-tetrofosmin and iodine131 in detecting differentiated thyroid carcinoma metastases. J Nucl Med 1998;39(11):1897-902.
    • (1998) J Nucl Med , vol.39 , Issue.11 , pp. 1897-1902
    • Unal, S.1    Menda, Y.2    Adalet, I.3
  • 55
    • 0028268001 scopus 로고
    • Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma
    • Sherman SI, Tielens ET, Sostre S, et al. Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma. J Clin Endocrinol Metab 1994;78(3):629-34.
    • (1994) J Clin Endocrinol Metab , vol.78 , Issue.3 , pp. 629-634
    • Sherman, S.I.1    Tielens, E.T.2    Sostre, S.3
  • 56
    • 0034457145 scopus 로고    scopus 로고
    • Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer?
    • Cailleux AF, Baudin E, Travagli JP, et al. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer?. J Clin Endocrinol Metab 2000;85(1):175-8.
    • (2000) J Clin Endocrinol Metab , vol.85 , Issue.1 , pp. 175-178
    • Cailleux, A.F.1    Baudin, E.2    Travagli, J.P.3
  • 57
    • 0030886175 scopus 로고    scopus 로고
    • Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma
    • Ladenson PW, Braverman LE, Mazzaferri EL, et al. Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med 1997;337(13):888-96.
    • (1997) N Engl J Med , vol.337 , Issue.13 , pp. 888-896
    • Ladenson, P.W.1    Braverman, L.E.2    Mazzaferri, E.L.3
  • 58
    • 0020508474 scopus 로고
    • The value of serum thyroglobulin measurement in clinical practice
    • Refetoff S, Lever EG. The value of serum thyroglobulin measurement in clinical practice. JAMA 1983;250(17):2352-7.
    • (1983) JAMA , vol.250 , Issue.17 , pp. 2352-2357
    • Refetoff, S.1    Lever, E.G.2
  • 59
    • 0021940361 scopus 로고
    • Correlation of thyroglobulin measurements and radioiodine scans in the follow-up of patients with differentiated thyroid cancer
    • Ramanna L, Waxman AD, Brachman MB, et al. Correlation of thyroglobulin measurements and radioiodine scans in the follow-up of patients with differentiated thyroid cancer. Cancer 1985;55(7):1525-9.
    • (1985) Cancer , vol.55 , Issue.7 , pp. 1525-1529
    • Ramanna, L.1    Waxman, A.D.2    Brachman, M.B.3
  • 60
    • 0021150692 scopus 로고
    • Thyroglobulin may be undetectable in the serum of patients with metastatic disease secondary to differentiated thyroid carcinoma. Follow-up of differentiated thyroid carcinoma
    • Grant S, Luttrell B, Reeve T, et al. Thyroglobulin may be undetectable in the serum of patients with metastatic disease secondary to differentiated thyroid carcinoma. Follow-up of differentiated thyroid carcinoma. Cancer 1984;54(8):1625-8.
    • (1984) Cancer , vol.54 , Issue.8 , pp. 1625-1628
    • Grant, S.1    Luttrell, B.2    Reeve, T.3
  • 61
    • 0025213050 scopus 로고
    • Low levels of serum thyroglobulin after withdrawal of thyroid suppression therapy in the follow up of differentiated thyroid carcinoma
    • Brendel AJ, Lambert B, Guyot M, et al. Low levels of serum thyroglobulin after withdrawal of thyroid suppression therapy in the follow up of differentiated thyroid carcinoma. Eur J Nucl Med 1990;16(1):35-8.
    • (1990) Eur J Nucl Med , vol.16 , Issue.1 , pp. 35-38
    • Brendel, A.J.1    Lambert, B.2    Guyot, M.3
  • 62
    • 0023603320 scopus 로고
    • Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels
    • Pacini F, Lippi F, Formica N, et al. Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med 1987;28(12):1888-91.
    • (1987) J Nucl Med , vol.28 , Issue.12 , pp. 1888-1891
    • Pacini, F.1    Lippi, F.2    Formica, N.3
  • 63
    • 0033341953 scopus 로고    scopus 로고
    • A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer
    • Haugen BR, Pacini F, Reiners C. et al. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 1999;84(11):3877-85.
    • (1999) J Clin Endocrinol Metab , vol.84 , Issue.11 , pp. 3877-3885
    • Haugen, B.R.1    Pacini, F.2    Reiners, C.3
  • 64
    • 0031671541 scopus 로고    scopus 로고
    • Immunoradiometric assay of thyroglobulin in patients with differentiated thyroid carcinomas: Need for thyroglobulin recovery tests
    • Bourrel F, Hoff M, Regis H, et al. Immunoradiometric assay of thyroglobulin in patients with differentiated thyroid carcinomas: need for thyroglobulin recovery tests. Clin Chem Lab Med 1998;36(9):725-30.
    • (1998) Clin Chem Lab Med , vol.36 , Issue.9 , pp. 725-730
    • Bourrel, F.1    Hoff, M.2    Regis, H.3
  • 65
    • 12244311334 scopus 로고    scopus 로고
    • Measuring the influence of thyroglobulin autoantibodies on serum thyroglobulin determinations in patients with thyroid carcinoma
    • Robbins R, Fleisher M. Measuring the influence of thyroglobulin autoantibodies on serum thyroglobulin determinations in patients with thyroid carcinoma. Thyroid 1999;9:41A.
    • (1999) Thyroid , vol.9
    • Robbins, R.1    Fleisher, M.2
  • 66
    • 0022388588 scopus 로고
    • Diagnostic value of a single serum thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer
    • Pacini F, Lari R, Mazzeo S, et al. Diagnostic value of a single serum thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer. Clin Endocrinol (Oxf) 1985;23(4):405-11.
    • (1985) Clin Endocrinol (Oxf) , vol.23 , Issue.4 , pp. 405-411
    • Pacini, F.1    Lari, R.2    Mazzeo, S.3
  • 67
    • 0036281001 scopus 로고    scopus 로고
    • Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?
    • Mazzaferri EL, Kloos RT. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?. J Clin Endocrinol Metab 2002;87(4):1490-8.
    • (2002) J Clin Endocrinol Metab , vol.87 , Issue.4 , pp. 1490-1498
    • Mazzaferri, E.L.1    Kloos, R.T.2
  • 68
    • 0036280909 scopus 로고    scopus 로고
    • Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment
    • Pacini F, Capezzone M, Elisei R, et al. Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. J Clin Endocrinol Metab 2002;87(4):1499-501.
    • (2002) J Clin Endocrinol Metab , vol.87 , Issue.4 , pp. 1499-1501
    • Pacini, F.1    Capezzone, M.2    Elisei, R.3
  • 69
    • 0035098314 scopus 로고    scopus 로고
    • Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma
    • Robbins RJ, Tuttle RM, Sharaf RN, et al. Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma. J Clin Endocrinol Metab 2001;86(2):619-25.
    • (2001) J Clin Endocrinol Metab , vol.86 , Issue.2 , pp. 619-625
    • Robbins, R.J.1    Tuttle, R.M.2    Sharaf, R.N.3
  • 70
    • 0036319730 scopus 로고    scopus 로고
    • Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma?
    • Robbins RJ, Chon JT, Fleisher M, et al. Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma? J Clin Endocrinol Metab 2002;87(7):3242-7.
    • (2002) J Clin Endocrinol Metab , vol.87 , Issue.7 , pp. 3242-3247
    • Robbins, R.J.1    Chon, J.T.2    Fleisher, M.3
  • 71
    • 0023099793 scopus 로고
    • Sonography in the follow-up of 100 patients with thyroid carcinoma
    • Simeone JF, Daniels GH, Hall DA, et al. Sonography in the follow-up of 100 patients with thyroid carcinoma. AJR Am J Roentgenol 1987;148(1):45-9.
    • (1987) AJR Am J Roentgenol , vol.148 , Issue.1 , pp. 45-49
    • Simeone, J.F.1    Daniels, G.H.2    Hall, D.A.3
  • 72
    • 85047680822 scopus 로고    scopus 로고
    • Combination of radioiodine (131I) and probeguided surgery for persistent or recurrent thyroid carcinoma
    • Travagli JP, Cailleux AF, Ricard M, et al. Combination of radioiodine (131I) and probeguided surgery for persistent or recurrent thyroid carcinoma. J Clin Endocrinol Metab 1998;83(8):2675-80.
    • (1998) J Clin Endocrinol Metab , vol.83 , Issue.8 , pp. 2675-2680
    • Travagli, J.P.1    Cailleux, A.F.2    Ricard, M.3
  • 73
    • 0031434133 scopus 로고    scopus 로고
    • High-resolution ultrasound associated with aspiration biopsy in the follow-up of patients with differentiated thyroid cancer
    • Rodriguez JM, Reus M, Moreno A, et al. High-resolution ultrasound associated with aspiration biopsy in the follow-up of patients with differentiated thyroid cancer. Otolaryngol Head Neck Surg 1997;117(6):694-7.
    • (1997) Otolaryngol Head Neck Surg , vol.117 , Issue.6 , pp. 694-697
    • Rodriguez, J.M.1    Reus, M.2    Moreno, A.3
  • 74
    • 0035948197 scopus 로고    scopus 로고
    • Ultrasound-guided fine-needle aspiration biopsy of the thyroid bed
    • Krishnamurthy S, Bedi DG, Caraway NP. Ultrasound-guided fine-needle aspiration biopsy of the thyroid bed. Cancer 2001;93(3):199-205.
    • (2001) Cancer , vol.93 , Issue.3 , pp. 199-205
    • Krishnamurthy, S.1    Bedi, D.G.2    Caraway, N.P.3
  • 75
    • 0023808716 scopus 로고
    • US-guided biopsy of neck masses in postoperative management of patients with thyroid cancer
    • Sutton RT, Reading CC, Charboneau JW, et al. US-guided biopsy of neck masses in postoperative management of patients with thyroid cancer. Radiology 1988;168(3):769-72.
    • (1988) Radiology , vol.168 , Issue.3 , pp. 769-772
    • Sutton, R.T.1    Reading, C.C.2    Charboneau, J.W.3
  • 76
    • 0023683665 scopus 로고
    • Recurrent thyroid carcinoma: Characteristics on MR images
    • Auffermann W, Clark OH, Thurnher S, et al. Recurrent thyroid carcinoma: characteristics on MR images. Radiology 1988;168(3):753-7.
    • (1988) Radiology , vol.168 , Issue.3 , pp. 753-757
    • Auffermann, W.1    Clark, O.H.2    Thurnher, S.3
  • 77
    • 0034754182 scopus 로고    scopus 로고
    • MRI detection of cervical metastasis from differentiated thyroid carcinoma
    • Gross ND, Weissman JL, Talbot JM, et al. MRI detection of cervical metastasis from differentiated thyroid carcinoma. Laryngoscope 2001;111(11 pt 1):1905-9.
    • (2001) Laryngoscope , vol.111 , Issue.11 PART 1 , pp. 1905-1909
    • Gross, N.D.1    Weissman, J.L.2    Talbot, J.M.3
  • 78
    • 0027228504 scopus 로고
    • Detection of recurrent thyroid cancer: MR versus thallium-201 scintigraphy
    • Ohnishi T, Noguchi S, Murakami N, et al. Detection of recurrent thyroid cancer: MR versus thallium-201 scintigraphy. AJNR Am J Neuroradiol 1993;14(5):1051-7.
    • (1993) AJNR Am J Neuroradiol , vol.14 , Issue.5 , pp. 1051-1057
    • Ohnishi, T.1    Noguchi, S.2    Murakami, N.3
  • 79
    • 0032231952 scopus 로고    scopus 로고
    • Papillary thyroid carcinoma: MR diagnosis of lymph node metastasis
    • Takashima S, Sone S, Takayama F, et al. Papillary thyroid carcinoma: MR diagnosis of lymph node metastasis. AJNR Am J Neuroradiol 1998;19(3):509-13.
    • (1998) AJNR Am J Neuroradiol , vol.19 , Issue.3 , pp. 509-513
    • Takashima, S.1    Sone, S.2    Takayama, F.3
  • 80
    • 0034105244 scopus 로고    scopus 로고
    • Staging papillary carcinoma of the thyroid: Magnetic resonance imaging vs ultrasound of the neck
    • King AD, Ahuja AT, To EW, et al. Staging papillary carcinoma of the thyroid: magnetic resonance imaging vs ultrasound of the neck. Clin Radiol 2000;55(3):222-6.
    • (2000) Clin Radiol , vol.55 , Issue.3 , pp. 222-226
    • King, A.D.1    Ahuja, A.T.2    To, E.W.3
  • 81
    • 0035218843 scopus 로고    scopus 로고
    • Advances in the detection of residual thyroid carcinoma
    • Robbins R, Drucker W, Hann L, et al. Advances in the detection of residual thyroid carcinoma. Adv Intern Med 2001;46:277-94.
    • (2001) Adv Intern Med , vol.46 , pp. 277-294
    • Robbins, R.1    Drucker, W.2    Hann, L.3
  • 82
    • 0030660494 scopus 로고    scopus 로고
    • Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer
    • Dietlein M, Scheidhauer K, Voth E, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 1997;24(11):1342-8.
    • (1997) Eur J Nucl Med , vol.24 , Issue.11 , pp. 1342-1348
    • Dietlein, M.1    Scheidhauer, K.2    Voth, E.3
  • 83
    • 0029779869 scopus 로고    scopus 로고
    • Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer
    • Feine U, Lietzenmayer R, Hanke JP, et al. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med 1996;37(9):1468-72.
    • (1996) J Nucl Med , vol.37 , Issue.9 , pp. 1468-1472
    • Feine, U.1    Lietzenmayer, R.2    Hanke, J.P.3
  • 84
    • 0029355220 scopus 로고
    • 18FDG-Ganzkorper-PET bei differenzierten schilddrusenkarzinouen flip flop in speichermuster von 18FDG und 131J
    • Feine U, Lietzenmayer R, Hanke JP, et al. 18FDG-Ganzkorper-PET bei differenzierten schilddrusenkarzinouen flip flop in Speichermuster von 18FDG und 131J [German]. [18FDG whole-body PET in differentiated thyroid carcinoma Flipflop in uptake patterns of 18FDG and 131I]. Nuklearmedizin 1995;34(4):127-34.
    • (1995) Nuklearmedizin , vol.34 , Issue.4 , pp. 127-134
    • Feine, U.1    Lietzenmayer, R.2    Hanke, J.P.3
  • 85
    • 9044246672 scopus 로고    scopus 로고
    • Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer
    • Grunwald F, Schomburg A, Bender H, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 1996;23(3):312-9.
    • (1996) Eur J Nucl Med , vol.23 , Issue.3 , pp. 312-319
    • Grunwald, F.1    Schomburg, A.2    Bender, H.3
  • 86
    • 0031822670 scopus 로고    scopus 로고
    • Evaluation of suspected recurrent papillary thyroid carcinoma with [18F] fluorodeoxyglucose positron emission tomography
    • Jadvar H, McDougall IR, Segall GM. Evaluation of suspected recurrent papillary thyroid carcinoma with [18F] fluorodeoxyglucose positron emission tomography. Nucl Med Commun 1998;19(6):547-54.
    • (1998) Nucl Med Commun , vol.19 , Issue.6 , pp. 547-554
    • Jadvar, H.1    McDougall, I.R.2    Segall, G.M.3
  • 87
    • 0034335410 scopus 로고    scopus 로고
    • Prognostic value of [18F] fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer
    • Wang W, Larson SM, Fazzari M, et al. Prognostic value of [18F] fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer. J Clin Endocrinol Metab 2000;85(3):1107-13.
    • (2000) J Clin Endocrinol Metab , vol.85 , Issue.3 , pp. 1107-1113
    • Wang, W.1    Larson, S.M.2    Fazzari, M.3
  • 88
    • 0034130683 scopus 로고    scopus 로고
    • FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma
    • Alnafisi NS, Driedger AA, Coates G, et al. FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma. J Nucl Med 2000;41(6):1010-5.
    • (2000) J Nucl Med , vol.41 , Issue.6 , pp. 1010-1015
    • Alnafisi, N.S.1    Driedger, A.A.2    Coates, G.3
  • 89
    • 0031712448 scopus 로고    scopus 로고
    • Positron emission tomography with F-18-deoxyglucose in patients with differentiated thyroid carcinoma, elevated thyroglobulin levels, and negative iodine scans
    • Altenvoerde G, Lerch H, Kuwert T, et al. Positron emission tomography with F-18-deoxyglucose in patients with differentiated thyroid carcinoma, elevated thyroglobulin levels, and negative iodine scans. Langenbecks Arch Surg 1998;383(2):160-3.
    • (1998) Langenbecks Arch Surg , vol.383 , Issue.2 , pp. 160-163
    • Altenvoerde, G.1    Lerch, H.2    Kuwert, T.3
  • 90
    • 0033003175 scopus 로고    scopus 로고
    • Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan
    • Chung JK, So Y, Lee JS, et al. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan. J Nucl Med 1999;40(6):986-92.
    • (1999) J Nucl Med , vol.40 , Issue.6 , pp. 986-992
    • Chung, J.K.1    So, Y.2    Lee, J.S.3
  • 91
    • 0032871248 scopus 로고    scopus 로고
    • Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography
    • Conti PS, Durski JM, Bacqai F, et al. Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography. Thyroid 1999;9(8):797-804.
    • (1999) Thyroid , vol.9 , Issue.8 , pp. 797-804
    • Conti, P.S.1    Durski, J.M.2    Bacqai, F.3
  • 92
    • 0033674689 scopus 로고    scopus 로고
    • Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma
    • Frilling A, Gorges R, Tecklenborg K, et al. Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma. Surgery 2000;128(6):1067-74.
    • (2000) Surgery , vol.128 , Issue.6 , pp. 1067-1074
    • Frilling, A.1    Gorges, R.2    Tecklenborg, K.3
  • 93
    • 0032589873 scopus 로고    scopus 로고
    • Non-131I-scintigraphy in the treatment and follow-up of thyroid cancer. Single-photon-emitters or FDG-PET?
    • Grunwald F, Briele B, Biersack HJ. Non-131I-scintigraphy in the treatment and follow-up of thyroid cancer. Single-photon-emitters or FDG-PET?. Q J Nucl Med 1999;43(3):195-206.
    • (1999) Q J Nucl Med , vol.43 , Issue.3 , pp. 195-206
    • Grunwald, F.1    Briele, B.2    Biersack, H.J.3
  • 94
    • 0031872806 scopus 로고    scopus 로고
    • Positron emission tomography for detecting iodine-131 nonvisualized metastasis of well-differentiated thyroid carcinoma: Two case reports
    • Huang TS, Chieng PU, Chang CC, et al. Positron emission tomography for detecting iodine-131 nonvisualized metastasis of well-differentiated thyroid carcinoma: two case reports. J Endocrinol Invest 1998;21(6):392-8.
    • (1998) J Endocrinol Invest , vol.21 , Issue.6 , pp. 392-398
    • Huang, T.S.1    Chieng, P.U.2    Chang, C.C.3
  • 95
    • 0033834592 scopus 로고    scopus 로고
    • Positron emission tomography for the detection of metastases of differentiated thyroid carcinoma
    • Lips P, Comans EF, Hoekstra OS, et al. Positron emission tomography for the detection of metastases of differentiated thyroid carcinoma. Neth J Med 2000;57(4):150-6.
    • (2000) Neth J Med , vol.57 , Issue.4 , pp. 150-156
    • Lips, P.1    Comans, E.F.2    Hoekstra, O.S.3
  • 96
    • 0033799734 scopus 로고    scopus 로고
    • Utility of fluorine-18-fluorodeoxyglucose positron emission tomography in differentiated thyroid carcinoma with negative radioiodine scans and elevated serum thyroglobulin levels
    • Muros MA. Llamas-Elvira JM, Ramirez-Navarro A, et al. Utility of fluorine-18-fluorodeoxyglucose positron emission tomography in differentiated thyroid carcinoma with negative radioiodine scans and elevated serum thyroglobulin levels. Am J Surg 2000;179(6):457-61.
    • (2000) Am J Surg , vol.179 , Issue.6 , pp. 457-461
    • Muros, M.A.1    Llamas-Elvira, J.M.2    Ramirez-Navarro, A.3
  • 97
    • 0032922782 scopus 로고    scopus 로고
    • LaPET-FDG en el cencer detiroides ante niveles altos de tiroglobulina y castro 131-I negativo. A proposito de un caso
    • Ortega F, Maldonado A, Maranes P, et al. LaPET-FDG en el cencer detiroides ante niveles altos de tiroglobulina y castro 131-I negativo. A proposito de un caso [Spanish]. [PET-FDG in thyroid cancer with high thyroglobulin levels and negative 131-I scan. A case report] Rev Esp Med Nucl 1999;18(1):50-4.
    • (1999) Rev Esp Med Nucl , vol.18 , Issue.1 , pp. 50-54
    • Ortega, F.1    Maldonado, A.2    Maranes, P.3
  • 98
    • 0033485825 scopus 로고    scopus 로고
    • The detection of small carcinoma with 18F-FDG using a dual head coincidence camera
    • Stokkel MP, Hoekstra A, van Rijk PP. The detection of small carcinoma with 18F-FDG using a dual head coincidence camera. Eur J Radiol 1999;32(3):160-2.
    • (1999) Eur J Radiol , vol.32 , Issue.3 , pp. 160-162
    • Stokkel, M.P.1    Hoekstra, A.2    Van Rijk, P.P.3
  • 99
    • 0033237663 scopus 로고    scopus 로고
    • [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels
    • Wang W, Macapinlac H, Larson SM, et al. [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels. J Clin Endocrinol Metab 1999;84(7):2291-302.
    • (1999) J Clin Endocrinol Metab , vol.84 , Issue.7 , pp. 2291-2302
    • Wang, W.1    Macapinlac, H.2    Larson, S.M.3
  • 100
    • 0028848228 scopus 로고
    • Cervical lymph node metastasis of thyroid papillary carcinoma imaged with fluorine-18-FDG, technetium-99m-pertechnetate and iodine-131-sodium iodide
    • Scott GC, Meier DA, Dickinson CZ. Cervical lymph node metastasis of thyroid papillary carcinoma imaged with fluorine-18-FDG, technetium-99m-pertechnetate and iodine-131-sodium iodide. J Nucl Med 1995;36(10):1843-5.
    • (1995) J Nucl Med , vol.36 , Issue.10 , pp. 1843-1845
    • Scott, G.C.1    Meier, D.A.2    Dickinson, C.Z.3
  • 101
    • 0027441026 scopus 로고
    • Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer: Implications for diagnosis and therapy
    • Sisson JC, Ackermann RJ, Meyer MA, et al. Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer: implications for diagnosis and therapy. J Clin Endocrinol Metab 1993;77(4):1090-4.
    • (1993) J Clin Endocrinol Metab , vol.77 , Issue.4 , pp. 1090-1094
    • Sisson, J.C.1    Ackermann, R.J.2    Meyer, M.A.3
  • 102
    • 0033457279 scopus 로고    scopus 로고
    • Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: Results of a multicentre study
    • Grunwald F, Kalicke T, Feine U, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur J Nucl Med 1999;26(12):1547-52.
    • (1999) Eur J Nucl Med , vol.26 , Issue.12 , pp. 1547-1552
    • Grunwald, F.1    Kalicke, T.2    Feine, U.3
  • 103
    • 0031663858 scopus 로고    scopus 로고
    • Histological verification of positive fluorine-18 fluorodeoxyglucose findings in patients with differentiated thyroid cancer
    • Schluter B, Grimm-Riepe C, Beyer W, et al. Histological verification of positive fluorine-18 fluorodeoxyglucose findings in patients with differentiated thyroid cancer. Langenbecks Arch Surg 1998;383(2):187-9.
    • (1998) Langenbecks Arch Surg , vol.383 , Issue.2 , pp. 187-189
    • Schluter, B.1    Grimm-Riepe, C.2    Beyer, W.3
  • 104
    • 0029855907 scopus 로고    scopus 로고
    • Detection of circulating thyroid cells in peripheral blood
    • Ditkoff BA, Marvin MR, Yemul S, et al. Detection of circulating thyroid cells in peripheral blood. Surgery 1996;120(6):959-64.
    • (1996) Surgery , vol.120 , Issue.6 , pp. 959-964
    • Ditkoff, B.A.1    Marvin, M.R.2    Yemul, S.3
  • 105
    • 0031934340 scopus 로고    scopus 로고
    • Detection of thyroglobulin, thyroid peroxidase, and RET/PTC-1 mRNA transcripts in the peripheral blood of patients with thyroid disease
    • Tallini G, Ghossein RA, Emanuel J, et al. Detection of thyroglobulin, thyroid peroxidase, and RET/PTC-1 mRNA transcripts in the peripheral blood of patients with thyroid disease. J Clin Oncol 1998;16(3):1148-66.
    • (1998) J Clin Oncol , vol.16 , Issue.3 , pp. 1148-1166
    • Tallini, G.1    Ghossein, R.A.2    Emanuel, J.3
  • 106
    • 0032461020 scopus 로고    scopus 로고
    • Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood
    • Ringel MD, Ladenson PW, Levine MA, et al. Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood. J Clin Endocrinol Metab 1998;83(12):4435-42.
    • (1998) J Clin Endocrinol Metab , vol.83 , Issue.12 , pp. 4435-4442
    • Ringel, M.D.1    Ladenson, P.W.2    Levine, M.A.3
  • 107
    • 0032992176 scopus 로고    scopus 로고
    • Quantitative reverse transcription-PCR measurement of thyroglobulin mRNA in peripheral blood of healthy subjects
    • Wingo ST, Ringel MD, Anderson JS, et al. Quantitative reverse transcription-PCR measurement of thyroglobulin mRNA in peripheral blood of healthy subjects. Clin Chem 1999;45(6 pt 1):785-9.
    • (1999) Clin Chem , vol.45 , Issue.6 PART 1 , pp. 785-789
    • Wingo, S.T.1    Ringel, M.D.2    Anderson, J.S.3
  • 108
    • 0033323803 scopus 로고    scopus 로고
    • Quantitative reverse transcriptionpolymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma
    • Ringel MD, Balducci-Silano PL, Anderson JS, et al. Quantitative reverse transcriptionpolymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma. J Clin Endocrinol Metab 1999;84(11):4037-42.
    • (1999) J Clin Endocrinol Metab , vol.84 , Issue.11 , pp. 4037-4042
    • Ringel, M.D.1    Balducci-Silano, P.L.2    Anderson, J.S.3
  • 109
    • 0027282562 scopus 로고
    • Surgical reintervention for differentiated thyroid cancer
    • Goretzki PE, Simon D, Frilling A, et al. Surgical reintervention for differentiated thyroid cancer. Br J Surg 1993;80(8):1009-12.
    • (1993) Br J Surg , vol.80 , Issue.8 , pp. 1009-1012
    • Goretzki, P.E.1    Simon, D.2    Frilling, A.3
  • 110
    • 0028302371 scopus 로고
    • Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131)
    • Coburn M, Teates D, Wanebo HJ. Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131) Ann Surg 1994;19(6):587-93.
    • (1994) Ann Surg , vol.19 , Issue.6 , pp. 587-593
    • Coburn, M.1    Teates, D.2    Wanebo, H.J.3
  • 111
    • 0026561556 scopus 로고
    • Management of local recurrence in welldifferentiated thyroid carcinoma
    • Hamby LS, McGrath PC, Schwartz RW, et al. Management of local recurrence in welldifferentiated thyroid carcinoma. J Surg Res 1992;52(2):113-7.
    • (1992) J Surg Res , vol.52 , Issue.2 , pp. 113-117
    • Hamby, L.S.1    McGrath, P.C.2    Schwartz, R.W.3
  • 112
    • 0030958526 scopus 로고    scopus 로고
    • The surgical management of laryngotracheal invasion by welldifferentiated papillary thyroid carcinoma
    • Czaja JM, McCaffrey TV. The surgical management of laryngotracheal invasion by welldifferentiated papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 1997;123(5):484-90.
    • (1997) Arch Otolaryngol Head Neck Surg , vol.123 , Issue.5 , pp. 484-490
    • Czaja, J.M.1    McCaffrey, T.V.2
  • 113
    • 0027933714 scopus 로고
    • Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine
    • Pacini F, Cetani F, Miccoli P, et al. Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine. World J Surg 1994;18(4):600-4.
    • (1994) World J Surg , vol.18 , Issue.4 , pp. 600-604
    • Pacini, F.1    Cetani, F.2    Miccoli, P.3
  • 114
    • 0026769603 scopus 로고
    • Radioiodine-131 therapy for welldifferentiated thyroid cancer-a quantitative radiation dosimetric approach: Outcome and validation in 85 patients
    • Maxon HR, Englaro EE, Thomas SR, et al. Radioiodine-131 therapy for welldifferentiated thyroid cancer-a quantitative radiation dosimetric approach: outcome and validation in 85 patients. J Nucl Med 1992;33(6):1132-6.
    • (1992) J Nucl Med , vol.33 , Issue.6 , pp. 1132-1136
    • Maxon, H.R.1    Englaro, E.E.2    Thomas, S.R.3
  • 115
    • 12244293919 scopus 로고
    • I-131 therapy for thyroid cancer: Quantitative dosimetric approach- outcome and validation in 85 patients
    • Maxon HR, Englaro EE, Thomas SR, et al. I-131 therapy for thyroid cancer: quantitative dosimetric approach- outcome and validation in 85 patients. J Nucl Med 1992;33(5):894.
    • (1992) J Nucl Med , vol.33 , Issue.5 , pp. 894
    • Maxon, H.R.1    Englaro, E.E.2    Thomas, S.R.3
  • 116
    • 0027016650 scopus 로고
    • Prognostic factors in differentiated carcinoma of the thyroid gland
    • Shah JP, Loree TR, Dharker D, et al. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 1992;164(6):658-61.
    • (1992) Am J Surg , vol.164 , Issue.6 , pp. 658-661
    • Shah, J.P.1    Loree, T.R.2    Dharker, D.3
  • 117
    • 0024239072 scopus 로고
    • Radioiodine therapy for differentiated thyroid carcinoma
    • Connor CS, Thomas JH, Robinson RG, et al. Radioiodine therapy for differentiated thyroid carcinoma. Am J Surg 1988;156(6):519-21.
    • (1988) Am J Surg , vol.156 , Issue.6 , pp. 519-521
    • Connor, C.S.1    Thomas, J.H.2    Robinson, R.G.3
  • 118
    • 0019880402 scopus 로고
    • 131I therapy in differentiated thyroid carcinoma: M.D. Anderson Hospital experience
    • 131I therapy in differentiated thyroid carcinoma: M.D. Anderson Hospital experience. Cancer 1981;47(4):664-71.
    • (1981) Cancer , vol.47 , Issue.4 , pp. 664-671
    • Maheshwari, Y.K.1    Hill, C.S.2    Haynie T.P. III3
  • 119
    • 0027429811 scopus 로고
    • Different features of pulmonary metastases in differentiated thyroid cancer: Natural history and multivariate statistical analysis of prognostic variables
    • Casara D, Rubello D, Saladini G, et al. Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 1993;34(10):1626-31.
    • (1993) J Nucl Med , vol.34 , Issue.10 , pp. 1626-1631
    • Casara, D.1    Rubello, D.2    Saladini, G.3
  • 120
    • 0030119620 scopus 로고    scopus 로고
    • Radioactive iodine treatment and external radiotherapy for long bone metastases from thyroid carcinoma
    • Schlumberger M, Challeton C, De Vathaire F, et al. Radioactive iodine treatment and external radiotherapy for long bone metastases from thyroid carcinoma. J Nucl Med 1996;37(4):598-605.
    • (1996) J Nucl Med , vol.37 , Issue.4 , pp. 598-605
    • Schlumberger, M.1    Challeton, C.2    De Vathaire, F.3
  • 121
    • 0024380917 scopus 로고
    • Clinical and biologic behavior of bone metastases from differentiated thyroid carcinoma
    • Marcocci C, Pacini F, Elisei R, et al. Clinical and biologic behavior of bone metastases from differentiated thyroid carcinoma. Surgery 1989;106(6):960-6.
    • (1989) Surgery , vol.106 , Issue.6 , pp. 960-966
    • Marcocci, C.1    Pacini, F.2    Elisei, R.3
  • 122
    • 0021333920 scopus 로고
    • Radioiodine treatment of metastatic thyroid carcioma: The Royal Marsden Hospital experience
    • Brown AP, Greening WP, McCready VR, et al. Radioiodine treatment of metastatic thyroid carcioma: the Royal Marsden Hospital experience. Br J Radiol 1984;57(676):323-7.
    • (1984) Br J Radiol , vol.57 , Issue.676 , pp. 323-327
    • Brown, A.P.1    Greening, W.P.2    McCready, V.R.3
  • 123
    • 0021354928 scopus 로고
    • Pulmonary metastases in differentiated thyroid carcinoma
    • Massin JP, Savoie JC, Garnier H, et al. Pulmonary metastases in differentiated thyroid carcinoma. Cancer 1984;53(4):982-92.
    • (1984) Cancer , vol.53 , Issue.4 , pp. 982-992
    • Massin, J.P.1    Savoie, J.C.2    Garnier, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.